Health in Guatemala 1,228 indicators covering health for Guatemala. IndicatorLatest Year10-yr change Rank Pancreatic cancer death rate 1.97 2022 down 27.5% 100th Brain and nervous system cancer death rate 1.29 2022 down 28.9% 100th Inflation-adjusted prices for most sold brand of cigarettes: Prices 5.8 2022 up 18.6% 101st Taxes as a % of price: total tax 49.0% 2022 unchanged 110th Taxes as a % of price: value added tax 10.7% 2022 unchanged 120th Taxes as a % of price: ad valorem excise 38.3% 2022 unchanged 28th Taxes as a % of price: specific excise 0.0% 2022 — 134th Taxes as a % of price: import duties 0.0% 2022 — 37th Taxes as a % of price: other taxes 0.0% 2022 — 56th Inflation-adjusted prices for most sold brand of cigarettes: Price in 22.5 2022 up 7.8% 105th Prevalence of severe wasting, weight for height 0.2% 2021 unchanged 75th Physical activity policies for activie societies 20 2023 unchanged 2nd Physical activity policies focused on active systems 10 2023 down 50.0% 99th Number of deaths from malaria who 0 2024 down 100.0% 66th Death rate from malaria 0 2024 down 100.0% 66th Incidence of malaria 0.21 2024 down 57.1% 68th Share of one year olds who received the final dose of pneumococcal vac 89 2024 up 43.5% 68th Diphtheria tetanus pertussis vaccine vs pneumococcal vaccine coverage 89 2024 up 43.5% 68th Death rate from poisonings 0.8 2021 down 27.3% 66th Mortality rate attributed to cardiovascular disease, cancer, diabetes 14.6 % 2021 down 0.7% 113th Mortality rate attributed to unintentional poisonings, by sex 0.8 per 100,000 people 2021 down 27.3% 60th Suicide mortality rate, by sex 4.9 per 100,000 people 2021 down 14.0% 116th Rotavirus number unvaccinated 33,178 2023 down 16.4% 50th Share of deaths registered 93.24 2019 — 89th Prevalence of stunting, height for age 46.0% 2021 down 10.7% 5th Affordability - percentage of GDP per capita required to purchase 5.84 2022 up 6.8% 59th Malaria cases reported 2,925 2024 down 40.7% 64th Deaths and missing persons due to natural disasters 1.6 2023 up 213.7% 49th Mean systolic blood pressure 119.1 2009 up 0.5% 168th Mean fasting blood glucose (mmol/l) 5.9 2009 up 5.4% 10th Hiv expenditure 60.88 million 2024 up 9.6% 31st Number of new leprosy cases with G2D among children 0 2024 — 35th Neonates protected at birth against neonatal tetanus (PAB) 90.0% 2022 up 5.9% 54th Prevalence of overweight, weight for height 4.9% 2015 down 5.8% 42nd Most sold brand of cigarettes - price in currency reported 20.5 2020 up 50.8% 112th Most sold brand of cigarettes - taxes as a % of price - total tax 0.5% 2020 down 5.8% 111th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.4% 2020 down 7.3% 26th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.1% 2020 unchanged 107th Most sold brand of cigarettes - taxes as a % of price - specific 0.0% 2020 — 128th Most sold brand of cigarettes - price in US$ at official exchange 2.66 2020 up 56.5% 94th Number healthy diet unaffordable 8.80 million 2024 up 4.8% 47th Import of environmentally sound technologies 887.37 million 2020 up 24.8% 79th Most sold brand of cigarettes - price in PPP$ 5.17 2020 up 33.6% 103rd Export of environmentally sound technologies 471.73 million 2020 up 44.5% 67th Pcv3 number unvaccinated 47,924 2023 down 56.9% 54th Reported number of human rabies deaths 0 2024 down 100.0% 62nd Proportion of births delivered in a health facility (Facility births) 71.0% 2021 up 21.2% 109th Number of non-autochthonous leprosy cases 0 2024 — 47th Prevalence of wasting, weight for height, female 0.6% 2021 down 40.0% 79th Prevalence of wasting, weight for height, male 1.0% 2021 unchanged 78th Number reported cases of cholera 1 2003 down 100.0% 85th Maternal mortality ratio 84 2023 down 25.7% 19th Population with basic handwashing facilities at home 69.9% 2019 unchanged 51st Prevalence of severe wasting, weight for height, female 0.0% 2021 down 100.0% 78th Prevalence of severe wasting, weight for height, male 0.3% 2021 up 50.0% 73rd Prevalence of overweight, weight for height, female 4.8% 2015 up 11.6% 35th Prevalence of overweight, weight for height, male 5.1% 2015 down 16.4% 39th HPV immunization coverage estimates among primary target cohort (9-14) 63.0% 2025 up 12.5% 75th ← Previous Page 18 of 21 Next →